Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Regeneron (NASDAQ: REGN) Delayed: 612.14 +0.66 (0.11%)
Previous Close $611.48    52 Week High $592.36 
Open $613.11    52 Week Low $325.35 
Day High $616.55    P/E 160.67 
Day Low $605.01    EPS $3.81 
Volume 717,681